查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
COVID-19 癌症免疫治療市場影響分析，按技術類型、按應用、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1335289

COVID-19 癌症免疫治療市場影響分析，按技術類型、按應用、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Cancer Immunotherapy Market with COVID-19 Impact Analysis, By Technology Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 321 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年癌症免疫治療市場規模為 879.086 億美元，2023 年至 2030 年年複合成長率為 13.8%。

癌症免疫治療市場-市場動態：

  • 癌症發病率的不斷上升和癌症治療技術進步的激增預計將推動全球癌症免疫治療市場的成長。
  • 不斷擴大的癌症負擔迫切需要更有效和量身定做的治療替代方案。癌症免疫療法在治療多種類型的癌症方面已顯示出令人鼓舞的結果，並逐漸被視為現代癌症治療技術的重要組成部分。根據美國疾病控制與預防中心的數據，2020年美國報告新增癌症病例1,603,844例，602,347人死於癌症。每10萬人中，新增癌症病例403例，144人死於癌症。 2020 年是可獲得發病率數據的最新一年。癌症研究領域的快速技術進步催生了新型定製藥物的誕生。尤其是免疫療法，隨著免疫檢查點抑製劑、CAR-T 細胞療法、癌症疫苗、溶瘤病毒和其他創新技術的出現，已經取得了相當大的進展。隨著新興國家醫療保健基礎設施的加速發展，癌症免疫療法將有更多的機會被採用。然而，高昂的費用可能會阻止許多患者獲得癌症免疫治療，特別是在不太富裕的國家或地區。

癌症免疫治療市場 - 主要見解：

  • 根據我們的研究分析師分享的分析，預計全球癌症免疫治療市場在預測期內（2023-2030）每年將以 13.8% 左右的年複合成長率成長
  • 由於人們對永續成長的認知不斷增強，癌症免疫治療行業預計將以顯著的速度成長
  • 根據產品類型細分，預計單克隆抗體將在 2022 年呈現最大市場佔有率
  • 根據應用細分，2022年肺癌為主導類型
  • 根據最終用戶細分，醫院是 2022 年的主導類型
  • 按地區分類，北美是 2022 年的主要收入來源

癌症免疫治療市場-細分分析：

  • 全球癌症免疫治療市場根據產品類型、應用、最終用戶和地區進行細分。
  • 根據產品類型，市場分為三類：單克隆抗體、細胞因子和免疫調節劑以及其他。單克隆抗體在市場上佔據主導地位。單克隆抗體（mAb）是一種癌症免疫療法，已成為治療各種癌症的重要組成部分。這些是實驗室製造的化合物，可以模仿免疫系統對抗癌細胞等危險感染的能力。
  • 根據應用，市場分為六類：肺癌、乳腺癌、結直腸癌、黑色素瘤、前列腺癌、頭頸癌等。肺癌在市場上佔據主導地位，並可能在預測期內保持其主導地位。免疫療法已成為肺癌治療方案的重要補充。多年來，化療和放療是肺癌的主要治療選擇。
  • 根據最終用戶，市場分為三類：醫院、癌症研究中心和診所。醫院領域主導著市場成長。癌症免疫療法廣泛應用於世界各地的醫院和診所，從小醫院到大型大學醫療機構。

癌症免疫治療市場-地理洞察：

從地域上看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。由於醫療保健支出增加、癌症發病率上升以及獲得醫療保險的人數激增，預計北美將主導市場成長。北美，尤其是美國，人均醫療保健支出比世界上任何其他國家都多。由於這種高水平的支出，公共和商業部門都可以投資於新穎且通常昂貴的癌症治療方法，例如免疫療法。根據美國醫學會的數據，2021 年美國醫療保健支出成長 2.7%，達到 4.3 兆美元，即人均 12,914 美元。健康保險的可用性會對患者接受及時和高品質護理的能力產生重大影響。由於該地區基礎設施的發展和癌症發病率的上升，歐洲是市場成長的第二大地區。

癌症免疫治療市場-競爭格局：

全球範圍內不斷擴大的癌症負擔以及免疫療法在治療特定形式癌症方面的既定療效增加了對癌症免疫療法的需求。該行業的公司經常在一些因素上展開競爭，例如特定療法的功效和安全性、其藥物可治療的惡性腫瘤範圍、定價以及向消費者展示其療法價值的能力。他們也在研發管線方面展開競爭，因為新藥和適應症可以提供競爭優勢。近年來，該領域出現了重大創新，導致了新療法和技術的發展。例如，2022 年 11 月，輝瑞公司宣布其在研癌症免疫療法 elranatamab 獲得美國食品和藥物管理局 (FDA) 的突破性療法認定，用於治療復發或難治性多發性骨髓瘤 (RRMM) 患者。

最近的發展：

2023 年6 月，默克公司（在美國和加拿大境外稱為MSD）宣布，美國食品和藥物管理局(FDA) 已接受新的補充生物製劑許可申請(sBLA) 的審查，該申請尋求批准默克公司的抗PD 藥物KEYTRUDA -1 療法與標準護理化療相結合，用於治療局部晚期不可逆或轉移性膽道癌 (BTC) 患者。

該研究的主要特點：

  • 這項關於癌症免疫治療市場的擬議研究提供了市場規模（百萬美元）、年複合成長率（CAGR%）和預測估計（2023-2030），以 2022 年為基準年
  • 該報告為客戶提供了有關癌症免疫治療市場的最新趨勢見解。
  • 該研究報告闡明了不同細分市場/國家的潛在成長機會，並解釋了癌症免疫治療市場有吸引力的投資主張矩陣
  • 總體報告確定了新的投資機會、老牌參與者面臨的挑戰以及癌症免疫治療市場維持的成長因素
  • COVID-19 對癌症免疫治療市場規模、預測、年複合成長率和市場動態的影響將在研究範圍下詳細討論。還將涵蓋對新冠疫情后癌症免疫治療市場的詳細見解。
  • 為了讓本報告的用戶全面了解癌症免疫治療市場，我們還包括了癌症免疫治療市場的競爭格局和關鍵創新者分析。
  • 該研究包括成長前景映射分析，其中所有行業細分都根據其市場規模、成長率和吸引力進行基準測試。
  • 該報告提供了主要市場參與者的詳細公司概況，這將幫助用戶了解在癌症免疫治療市場營運的參與者的財務資訊和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要參與者的重要收購和兼併、合作和合資、新產品推出、研發、區域擴張。
  • 全球癌症免疫治療市場報告主要面向該行業的各個利益相關者，包括供應商、投資者、新進入者、分銷商和財務分析師

目錄

第一章：癌症免疫治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按技術類型分類的癌症免疫治療市場片段
    • 癌症免疫治療市場片段（按應用）
    • 最終用戶的癌症免疫治療市場片段
    • 按國家/地區分類的癌症免疫治療市場片段
    • 按地區分類的癌症免疫治療市場片段
  • 競爭洞察

第 3 章：癌症免疫治療主要市場趨勢

  • 癌症免疫治療市場促進因素
    • 市場促進因素的影響分析
  • 癌症免疫治療市場限制
    • 市場限制影響分析
  • 癌症免疫治療市場機會
  • 癌症免疫治療市場未來趨勢

第 4 章：癌症免疫治療行業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：癌症免疫治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的細分市場
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：癌症免疫治療市場格局

  • 2022 年癌症免疫治療市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：癌症免疫治療市場 - 按技術類型

  • 概述
    • 按技術類型分類的細分市場佔有率分析
    • 單克隆抗體
    • 細胞因子和免疫調節劑
    • 其他

第 8 章：癌症免疫治療市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 肺癌
    • 乳癌
    • 結直腸癌
    • 黑色素瘤
    • 前列腺癌
    • 頭頸癌
    • 其他

第 9 章：癌症免疫治療市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 癌症研究中心
    • 診所

第 10 章：癌症免疫治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美
    • 概述
    • 北美癌症免疫療法主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按技術類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲癌症免疫療法主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按技術類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區癌症免疫療法主要製造商
    • 亞太地區市場規模和預測（按國家）
    • 亞太地區市場規模和預測（按技術類型）
    • 亞太地區市場規模和預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲癌症免疫療法主要製造商
    • 拉丁美洲市場規模和預測（按國家）
    • 拉丁美洲市場規模和預測（按技術類型）
    • 拉丁美洲市場規模和預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲癌症免疫療法主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按技術類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 火雞
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析-癌症免疫治療行業

  • 競爭儀表板
  • 公司簡介
    • Pfizer Inc.
    • AstraZeneca
    • Merck & Co., Inc
    • F. Hoffmann-La Roche Ltd
    • Bristol-Myers Squibb Company
    • Novartis AG
    • Lilly
    • Johnson & Johnson Services, Inc
    • Immunocore, Ltd

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯繫我們
Product Code: ANV1564

REPORT HIGHLIGHT

The Cancer Immunotherapy Market size was valued at USD 87,908.6 Million in 2022, expanding at a CAGR of 13.8% from 2023 to 2030.

Cancer immunotherapy is a sort of cancer treatment that uses the body's own immune system to combat cancer. It works by assisting the immune system in recognizing and attacking cancer cells. Immunotherapy can be used alone or in conjunction with other cancer treatments. Cancer frequently overcomes many of the immune system's natural defenses, allowing cancer cells to proliferate. Different types of immunotherapy work in different ways. Some immunotherapy treatments assist the immune system block or limiting the growth of cancer cells. Others aid the immune system in destroying cancer cells or preventing cancer from spreading to other parts of the body. Immunotherapy has shown promise in treating a variety of cancers and has become a major focus of cancer research.

Cancer Immunotherapy Market- Market Dynamics:

  • The growing incidence of cancer and the surge in technological advancements in cancer treatment therapies are expected to propel the growth of the global cancer immunotherapy market.
  • The expanding cancer burden has produced a critical demand for more effective and tailored treatment alternatives. Cancer immunotherapy has demonstrated encouraging outcomes in treating several types of cancer and is gradually being regarded as an important component of modern cancer treatment techniques. According to the Centers for disease control and Prevention, In the United States in 2020, 1,603,844 new cancer cases were reported and 602,347 people died of cancer. For every 100,000 people, 403 new cancer cases were reported and 144 people died of cancer. 2020 is the latest year for which incidence data are available. Rapid technological advances in cancer research have resulted in the creation of novel and tailored medicines. Immunotherapy, in particular, has made considerable advances in recognition of the advent of immune checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, oncolytic viruses, and other innovative techniques. As healthcare infrastructure in emerging nations accelerates, there will be greater opportunities for cancer immunotherapies to be adopted. However, High expenses can prevent many patients from gaining Cancer Immunotherapy, particularly in less rich nations or regions.

Cancer Immunotherapy Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Cancer Immunotherapy market is estimated to grow annually at a CAGR of around 13.8% over the forecast period (2023-2030)
  • The Cancer Immunotherapy industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on product type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Lung Cancer was the leading type in 2022
  • Based on End-User segmentation, Hospitals was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Cancer Immunotherapy Market- Segmentation Analysis:

  • The Global Cancer Immunotherapy Market is segmented on the basis of Product Type, Application, End-User, and Region.
  • The market is divided into three categories based on product type: Monoclonal Antibodies, Cytokines & Immunomodulators, and Others. Monoclonal Antibodies dominate the market. Monoclonal antibodies (mAbs) are a type of cancer immunotherapy that has become an essential component in the treatment of various cancers. These are lab-created compounds that can imitate the immune system's ability to combat dangerous infections such as cancer cells.
  • The market is divided into six categories based on application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others. Lung Cancer dominates the market and is likely to maintain its dominance during the forecast period. Immunotherapy has emerged as an important complement to lung cancer treatment options. Chemotherapy and radiation were the principal treatment choices for lung cancer for many years.
  • The market is divided into three categories based on End-User: Hospitals, Cancer Research Centers, and Clinics. The hospital segment dominates the market growth. Cancer immunotherapy is widely employed in hospitals and clinics all over the world, from small hospitals to large university medical institutes.

Cancer Immunotherapy Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, owing to an increase in healthcare expenditure, a rise in the incidence of cancer, and a surge in access to medical insurance. North America, especially the United States, spends more per capita on healthcare than any other country in the world. Because of this high level of spending, both the public and commercial sectors can invest in novel and frequently expensive cancer treatments, such as immunotherapies. According to American Medical Association, Health spending in the U.S. increased by 2.7% in 2021 to USD 4.3 trillion or USD12,914 per capita. The availability of health insurance can have a substantial impact on a patient's capacity to receive timely and high-quality care. Europe is the second largest region for the growth of the market, owing to the development in the infrastructure in the region and rising incidences of cancer.

Cancer Immunotherapy Market- Competitive Landscape:

The expanding worldwide burden of cancer and the established efficacy of immunotherapies in treating specific forms of cancer have increased the demand for cancer immunotherapy. Companies in this industry frequently compete on factors such as particular treatments' efficacy and safety profile, the spectrum of malignancies their medications can treat, pricing, and their ability to demonstrate the value of their therapies to consumers. They compete in terms of their R&D pipelines as well, as novel medicines and indications can provide a competitive advantage. This field has seen major innovation in recent years, leading to the development of new therapies and techniques. For example, on November 2022, Pfizer Inc. nowadays announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the treatment of people with relapsed or refractory multiple myeloma (RRMM).

Recent Developments:

On June 2023, Merck, known as MSD outside of the United States and Canada, nowadays announced the U.S. Food and Drug Administration (FDA) has accepted for review a new supplemental Biologics License Application (sBLA) seeking approval for KEYTRUDA, Merck's anti-PD-1 therapy, in combination with standard of care chemotherapy for the treatment of patients with locally advanced unrespectable or metastatic biliary tract cancer (BTC).

Key features of the study:

  • This proposed research study on Cancer Immunotherapy market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Cancer Immunotherapy market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cancer Immunotherapy market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cancer Immunotherapy market
  • Impact of COVID-19 on Cancer Immunotherapy market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cancer Immunotherapy market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Cancer Immunotherapy market, we have also included competitive landscape and key innovator analysis for the Cancer Immunotherapy market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Cancer Immunotherapy market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Cancer Immunotherapy market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER IMMUNOTHERAPY MARKET KEY PLAYERS

  • Pfizer Inc.
  • AstraZeneca
  • Merck & Co., Inc
  • F. Hoffmann-La Roche Ltd
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Lilly
  • Johnson & Johnson Services, Inc
  • Immunocore, Ltd

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY TECHNOLOGY TYPE

  • Monoclonal Antibodies
  • Cytokines & Immunomodulators
  • Others

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY APPLICATION

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Head & Neck Cancer
  • Others

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY END-USER

  • Hospitals
  • Cancer Research Centers
  • Clinics

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Immunotherapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Immunotherapy Market Snippet by Technology Type
    • 2.1.2. Cancer Immunotherapy Market Snippet by Application
    • 2.1.3. Cancer Immunotherapy Market Snippet by End-User
    • 2.1.4. Cancer Immunotherapy Market Snippet by Country
    • 2.1.5. Cancer Immunotherapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Immunotherapy Key Market Trends

  • 3.1. Cancer Immunotherapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Immunotherapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Immunotherapy Market Opportunities
  • 3.4. Cancer Immunotherapy Market Future Trends

4. Cancer Immunotherapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Immunotherapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Immunotherapy Market Landscape

  • 6.1. Cancer Immunotherapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Immunotherapy Market - By Technology Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology Type, 2022 & 2030 (%)
    • 7.1.2. Monoclonal Antibodies
    • 7.1.3. Cytokines & Immunomodulators
    • 7.1.4. Others

8. Cancer Immunotherapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Lung Cancer
    • 8.1.3. Breast Cancer
    • 8.1.4. Colorectal Cancer
    • 8.1.5. Melanoma
    • 8.1.6. Prostate Cancer
    • 8.1.7. Head & Neck Cancer
    • 8.1.8. Others

9. Cancer Immunotherapy Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Cancer Research Centers
    • 9.1.4. Clinics

10. Cancer Immunotherapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cancer Immunotherapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cancer Immunotherapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cancer Immunotherapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cancer Immunotherapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cancer Immunotherapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Cancer Immunotherapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. AstraZeneca
    • 11.2.3. Merck & Co., Inc
    • 11.2.4. F. Hoffmann-La Roche Ltd
    • 11.2.5. Bristol-Myers Squibb Company
    • 11.2.6. Novartis AG
    • 11.2.7. Lilly
    • 11.2.8. Johnson & Johnson Services, Inc
    • 11.2.9. Immunocore, Ltd

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Immunotherapy Market: Technology Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology Type
  • TABLE Global Cancer Immunotherapy Market, by Technology Type 2018-2030 (USD Million)
  • TABLE Cancer Immunotherapy Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer Immunotherapy Market, by Application 2018-2030 (USD Million)
  • TABLE Cancer Immunotherapy Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Cancer Immunotherapy Market, by End-User 2018-2030 (USD Million)
  • TABLE Cancer Immunotherapy Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Immunotherapy Market, by Region 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Cancer Immunotherapy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Technology Type segment market share analysis, 2022 & 2030
  • FIGURE Technology Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Europe Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Asia Pacific Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Latin America Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Middle East and Africa Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE Germany Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE India Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE Brazil Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE Saudi Arabia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)